Ariosa, LabCorp Partner to Make T21 Test Available | GenomeWeb

NEW YORK (GenomeWeb News) – Ariosa Diagnostics today announced a partnership with Laboratory Corporation of America and Integrated Genetics to make its T21 test available in the US and Canada.

Integrated Genetics is a member of LabCorp's Specialty Testing Group. Financial and other terms of the deal were not disclosed.

Ariosa's test, called the Harmony Prenatal Test, will be offered through LabCorp and its more-than-1,000 patient service centers. The test is being made available at select locations and will be broadly launched next month, Ariosa said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.